Search results
TEVA Q2 Earnings & Sales Top as Austedo Outperforms, Stock Up
Zacks via Yahoo Finance· 9 months agoTeva Pharmaceutical Industries Limited TEVA reported second-quarter 2023 adjusted earnings of 56...
Teva Pharmaceutical Industries Ltd (TEVA) Reports Solid Growth in 2023 Earnings
GuruFocus.com via Yahoo Finance· 3 months agoRevenue Growth: TEVA reported a 7% increase in local currency terms for 2023, reaching $15.8...
Teva's Migraine Treatment Effective In Patients With Co-Morbid Depression
Benzinga via Yahoo Finance· 2 years agoTeva Pharmaceutical Industries Ltd (NYSE: TEVA) announced the results of two studies presented at...
Teva Pharmaceutical: Long-Term Cash Cow
GuruFocus.com via Yahoo Finance· 5 months agoTeva Pharmaceutical Industries (NYSE:TEVA) is one of the leading companies in the healthcare sector, specializing in developing and commercializing...
Eli Lilly ordered to pay $176.5 million to Teva in U.S. migraine drug patent trial
Reuters via Yahoo Finance· 1 year agoEli Lilly & Co must pay Teva Pharmaceuticals International GmbH $176.5 million after a trial to...
TEVA Beats Q4 Earnings Estimates, Sales Miss & Stock Down
Zacks via Yahoo Finance· 1 year agoTeva Pharmaceutical Industries Limited TEVA reported fourth-quarter 2022 adjusted earnings of 71...
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case
Reuters via Yahoo News· 7 months agoDrugmaker Eli Lilly convinced a federal judge in Massachusetts on Tuesday to overturn a $176.5...
Teva, GSK Put Up Bullish Fourth-Quarter Performances. Here's Where Novartis Fell Short.
Investor's Business Daily· 3 months agoTeva stock neared a profit-taking zone Wednesday, while GSK stock — a fellow pharma Goliath —...
Teva Guides To Its First Year Of Growth Since 2017 — But Shares Tumbled On This Caveat
Investor's Business Daily· 1 year agoTeva Pharmaceutical expects 2023 sales to grow for the first time in six years, but its outlook...
Teva Pharmaceutical Industries (TEVA) Q4 2023 Earnings Call Transcript
Motley Fool via Yahoo Finance· 3 months agoImage source: The Motley Fool. Teva Pharmaceutical Industries (NYSE: TEVA) Q4 2023 Earnings Call Jan...